EPISODE · Oct 7, 2024 · 10 MIN
Heart failure risk assessment using biomarkers in patients with atrial fibrillation: Analysis from COMBINE-AF
from JACC This Week
In the October 15, 2024 issue of JACC, a study led by Dr. Paul Haller investigates the use of biomarkers—NT-proBNP, high-sensitive cardiac troponin T, and GDF-15—to assess heart failure risk in patients with atrial fibrillation. The findings reveal that these biomarkers significantly enhance risk stratification, suggesting their potential to identify patients at varying risks for heart failure and improve clinical management.
NOW PLAYING
Heart failure risk assessment using biomarkers in patients with atrial fibrillation: Analysis from COMBINE-AF
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 3, 2026 ·44m
Feb 21, 2026 ·30m
Jan 2, 2026 ·47m